AU5607873A - Tetrahydrocarbazole derivatives - Google Patents

Tetrahydrocarbazole derivatives

Info

Publication number: AU5607873A
Authority: AU; Australia
Prior art keywords: tetrahydrocarbazole derivatives; tetrahydrocarbazole; derivatives
Prior art date: 1972-05-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

AU56078/73A

Other languages

English (en)

Inventor

Helmut Biere

Olaf Loge

Clemens Rufer

Ekkehard Schillinger

Hanns Ahrens

Eberhard Schroeder

Wolfgang Losert

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharma AG

Original Assignee

Schering AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-05-25

Filing date

1973-05-24

Publication date

1974-11-28

1973-05-24 Application filed by Schering AG filed Critical Schering AG

1974-11-28 Publication of AU5607873A publication Critical patent/AU5607873A/en

Status Expired legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

AU56078/73A 1972-05-25 1973-05-24 Tetrahydrocarbazole derivatives Expired AU5607873A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19722226703 DE2226703A1 (de)	1972-05-25	1972-05-25	Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number	Publication Date
AU5607873A true AU5607873A (en)	1974-11-28

Family

ID=5846530

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU56078/73A Expired AU5607873A (en)	1972-05-25	1973-05-24	Tetrahydrocarbazole derivatives

Country Status (12)

Country	Link
JP (1)	JPS4941367A (de)
AT (1)	AT323155B (de)
AU (1)	AU5607873A (de)
BE (1)	BE800066A (de)
CA (1)	CA1005062A (de)
CH (1)	CH582144A5 (de)
CS (1)	CS179416B2 (de)
DD (1)	DD106170A5 (de)
DE (1)	DE2226703A1 (de)
FR (1)	FR2185414B1 (de)
GB (1)	GB1436893A (de)
NL (1)	NL7307313A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4235903A (en) *	1979-08-06	1980-11-25	American Home Products Corporation	1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US7361680B2 (en)	1999-07-23	2008-04-22	The Regents Of The University Of California	Indole compounds useful for the treatment of cancer
US7105560B1 (en)	1999-07-23	2006-09-12	The Regents Of The University Of California	Use of etodolac in the treatment of multiple myeloma
US7151100B1 (en)	1999-07-23	2006-12-19	The Regents Of The University Of California	Indole compounds useful for the treatment of cancer
US7129262B2 (en)	1999-07-23	2006-10-31	The Regents Of The University Of California	Indole compounds useful for the treatment of cancer
US6545034B1 (en)	1999-07-23	2003-04-08	The Regents Of The University Of California	Use of etodolac for the treatment of chronic lymphocytic leukemia
DE10164564B4 (de) *	2001-12-14	2007-05-16	Zentaris Gmbh	Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
AU2003295336A1 (en)	2002-09-19	2004-04-08	Dennis A. Carson	Use of etodoclac to treat hyperplasia
US20050209300A1 (en) *	2003-09-12	2005-09-22	Andrew Napper	Methods of treating a disorder
US20060074124A1 (en) *	2003-09-12	2006-04-06	Andrew Napper	Methods of treating a disorder
EP1673373A2 (de) *	2003-10-02	2006-06-28	Salmedix, Inc.	Indolderivate
HUE030424T2 (en) *	2008-07-23	2017-05-29	Arena Pharm Inc	Substituted 1,2,3,4-tetrahydrocyclopenta [b] indol-3-ylacetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
BRPI0917923B1 (pt)	2008-08-27	2022-04-05	Arena Pharmaceuticals Inc	Derivado de ácido tricíclico substituído, sua composição, seu uso e processo para preparar a referida composição
EP3378854B1 (de)	2010-01-27	2022-12-21	Arena Pharmaceuticals, Inc.	Verfahren zur herstellung von (r)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)essigsäure und salzen davon
JP2013521301A (ja)	2010-03-03	2013-06-10	アリーナファーマシューティカルズ，インコーポレイテッド	Ｓ１ｐ１受容体修飾物質およびその結晶形の調製のためのプロセス
MX2021011472A (es)	2015-01-06	2022-08-17	Arena Pharm Inc	Metodos de condiciones de tratamiento relacionadas con el receptor s1p1.
KR102603199B1 (ko)	2015-06-22	2023-11-16	아레나 파마슈티칼스, 인크.	Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염
WO2018151873A1 (en)	2017-02-16	2018-08-23	Arena Pharmaceuticals, Inc.	Compounds and methods for treatment of primary biliary cholangitis
CA3053416A1 (en)	2017-02-16	2018-08-23	Arena Pharmaceuticals, Inc.	Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
EP3847158A1 (de)	2018-09-06	2021-07-14	Arena Pharmaceuticals, Inc.	Verbindungen zur verwendung bei der behandlung von autoimmun- und entzündlichen erkrankungen
CN114634442B (zh) *	2022-04-02	2023-10-13	内蒙古民族大学	一种四氢咔唑酮化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH586678A5 (de) *	1970-05-25	1977-04-15	Hoffmann La Roche
ZA715217B (en) *	1970-08-20	1972-04-26	Org Nv	Anti-inflammatory preparations

1972
- 1972-05-25 DE DE19722226703 patent/DE2226703A1/de active Pending
1973
- 1973-04-17 DD DD17023273A patent/DD106170A5/xx unknown
- 1973-05-14 GB GB2279573A patent/GB1436893A/en not_active Expired
- 1973-05-16 CS CS350973A patent/CS179416B2/cs unknown
- 1973-05-17 CH CH707473A patent/CH582144A5/xx not_active IP Right Cessation
- 1973-05-23 AT AT449173A patent/AT323155B/de not_active IP Right Cessation
- 1973-05-24 AU AU56078/73A patent/AU5607873A/en not_active Expired
- 1973-05-25 CA CA172,234A patent/CA1005062A/en not_active Expired
- 1973-05-25 BE BE131549A patent/BE800066A/xx unknown
- 1973-05-25 NL NL7307313A patent/NL7307313A/xx not_active Application Discontinuation
- 1973-05-25 JP JP5848173A patent/JPS4941367A/ja active Pending
- 1973-05-25 FR FR7319087A patent/FR2185414B1/fr not_active Expired

Also Published As

Publication number	Publication date
CA1005062A (en)	1977-02-08
JPS4941367A (de)	1974-04-18
BE800066A (fr)	1973-11-26
DE2226703A1 (de)	1973-12-13
FR2185414B1 (de)	1976-08-13
DD106170A5 (de)	1974-06-05
CH582144A5 (de)	1976-11-30
CS179416B2 (en)	1977-10-31
GB1436893A (en)	1976-05-26
AT323155B (de)	1975-06-25
NL7307313A (de)	1973-11-27
FR2185414A1 (de)	1974-01-04

Publication	Publication Date	Title
IL43795A (en)	1978-03-10	3-aminoalkylamino-1-phenoxy-2-propanol derivatives
AU5607873A (en)	1974-11-28	Tetrahydrocarbazole derivatives
ZA728544B (en)	1974-02-27	Alpha-aryl-4-substituted piperidinoalkanol derivatives
ZA736059B (en)	1974-08-28	New quinoxaline-di-n-oxide derivatives
ZA73619B (en)	1973-10-31	Indole derivatives
CY992A (en)	1979-08-02	Benzocycloheptathiophene derivatives
GB1402219A (en)	1975-08-06	Berbine derivatives
ZA728917B (en)	1973-11-28	Oxaziniondole-and thiaziniondole derivatives
IL42943A (en)	1978-04-30	16-methyl-prednisolone derivatives
IL43280A0 (en)	1973-11-28	Amidinourea derivatives
ZA731557B (en)	1973-11-28	Diphenylalkyllactamimide derivatives
PH10465A (en)	1977-04-25	Debenzazecine derivatives
GB1405227A (en)	1975-09-10	Pheynlthioethyl-imidazole derivatives
KE2917A (en)	1979-03-09	New phenylformamidine derivatives
ZA728875B (en)	1974-07-31	Pyrano-and thiopyranoindole derivatives
ZA734945B (en)	1974-11-27	New beta-aminoketone derivatives
MY7800240A (en)	1978-12-31	Indole derivatives
ZA738209B (en)	1974-09-25	Carbazole derivatives
HK380A (en)	1980-01-11	Benzoisoindoline derivatives
PH10601A (en)	1977-07-15	Diaza-oxa-bicyclodecane derivatives
PH10653A (en)	1977-07-27	Indolylimidoylquinoline derivatives
AU5872373A (en)	1975-02-06	Isoxolidine derivatives
AU5423773A (en)	1974-10-10	Alpha-pyrone derivatives
AU5667373A (en)	1974-12-12	Benzodaizepine derivatives benzodaizepine derivatives
IL43673A0 (en)	1974-03-14	Fluorenthane derivatives